Genomic profiles of glioma Journal Article


Author: Brennan, C.
Article Title: Genomic profiles of glioma
Abstract: Recent large-scale genomic profiling studies of glioma have yielded a proliferation of candidate subclasses, biomarkers and therapeutic targets for investigation. Some findings, such as that of IDH mutation in low-grade gliomas and secondary glioblastoma (GBM), fit well into established notions of different routes of gliomagenesis. Other results, such as the division of primary GBM based on signaling pathway alterations, suggest new pathogenetic routes with implications for treatment. The analysis of this data is still in the early stage. Nonetheless, several preliminary findings merit consideration in the development and interpretation of current clinical trials. © Springer Science+Business Media, LLC 2011.
Keywords: vasculotropin; cancer survival; primary tumor; unclassified drug; gene mutation; sequence analysis; histopathology; cancer staging; glioma; cancer grading; cell proliferation; tumor differentiation; transcriptomics; phosphatidylinositol 3 kinase; protein p53; tumor marker; carcinogenesis; gene expression regulation; genome analysis; oncogene; tumor suppressor gene; diagnostic value; early cancer; glioblastoma; cyclin dependent kinase inhibitor 2a; egfr gene; cancer classification; neuropathology; isocitrate dehydrogenase; idh; isocitrate dehydrogenase 1; isocitrate dehydrogenase isoenzyme; molecular subclassification; tcga; cdkn2a gene; isocitrate dehydrogenase 1 gene; isocitrate dehydrogenase 2 gene
Journal Title: Current Neurology and Neuroscience Reports
Volume: 11
Issue: 3
ISSN: 1528-4042
Publisher: Springer  
Date Published: 2011-06-01
Start Page: 291
End Page: 297
Language: English
DOI: 10.1007/s11910-011-0198-7
PUBMED: 21465149
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 3 October 2011" - "CODEN: CNNRB" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Cameron Brennan
    226 Brennan